Objective: Recent epidemiological and prospective trial evidence suggests that consumption of a low glycaemic index (LGI) diet will reduce coronary risk. We hypothesise that introduction of an LGI diet will improve the metabolic profile of patients who have undergone coronary artery bypass grafting. Design: We conducted a randomised parallel group trial comparing a control group (n ¼ 29, age 61.879 y), who received currently advocated healthy eating dietary advice only, to an intervention group, who received healthy eating advice emphasising LGI carbohydrates (n ¼ 26, age 63.679.4 y) over a 12-week period in free-living patients with coronary heart disease. Outcome measures included fasting glucose, insulin, total cholesterol, high-density lipoprotein cholesterol, very lowdensity lipoprotein cholesterol, low density lipoprotein cholesterol and triglycerides. Results: A significant lower dietary glycaemic index was achieved in the group assigned to an LGI diet compared to the healthy eating control group (7171 vs 8171); fibre intake was also higher in the LGI group (2071 vs 1571 g). All biochemical markers of glucose and lipid metabolism measured were similar after 12 weeks of the LGI diet or control diet. Discussion: The LGI group achieved a significant LGI and a higher dietary fibre intake. However, there was no measurable significant effect of either the LGI diet or the health eating diet on lipid levels; this may have been hidden by concurrent drug therapy.
Introduction
Coronary heart disease (CHD) remains the major cause of death in the Western world (Murray & Lopez, 1997) . Modest falls in CHD mortality during the last three decades have been attributed to modification of conventional CHD risk factors (Gillum, 1994) . Insulin resistance and the metabolic syndrome is increasingly recognised as an important risk factors for CHD (Reavan, 1994) . This syndrome is characterised by central obesity, hypertension, hyperinsulinaemia, glucose intolerance, hypertriglyceridaemia, low high-density lipoprotein cholesterol (HDL-cholesterol), increased small dense low-density lipoprotein cholesterol (LDL-cholesterol), and high plasminogen activator inhibitor-1 (PAI-1) levels (Reavan, 1994) , factors that alone or collectively increase CHD risk. Few studies have examined the effects of improved insulin sensitivity on CHD risk factors in the population.
Dietary carbohydrates can be subdivided into low glycaemic index (LGI) and high glycaemic index (HGI) carbohydrates, which have different effects on postprandial glucose and insulin (Frost et al, 1996) . LGI carbohydrates produce lower postprandial blood glucose and insulin concentrations than HGI carbohydrates (Jenkins et al, 1981) . We have shown that LGI diets are associated with reductions in fasting and postprandial insulin, glucose, triacylglyceride (TG) and nonesterified fatty acid (NEFA) in subjects with CHD or at risk of CHD (Frost et al, 1996 (Frost et al, , 1998 . Insulin sensitivity in subjects with CHD, obesity and diabetes, as well as those at risk of CHD, is improved following 3 months of dietary intervention with LGI diets (Frost et al, 1996 (Frost et al, , 1998 . Similar findings have been reported in patients with type II diabetes in whom LGI diets lowered fasting total cholesterol, very low-density lipoprotein (VLDL) concentrations and increased HDL concentrations and reduced PAI levels (Jarvi et al, 1999) . In addition, LGI has been shown prospectively to have additional short-term benefits (Frost et al, 1994) , improving clotting parameters by suppressing plasminogen activator inhibitor compound-1 (Jarvi et al, 1999) , reducing blood pressure (Sciarrone et al, 1993) and inducing weight loss (Slabber et al, 1994) . Also in a group of people who were hyperlipidaemic, the addition of low-glycaemic diet to the standard healthy eating advice produced a significant decrease in total cholesterol and TG concentrations. We have observed in our own studies a decrease in total cholesterol. Recent epidemiological evidence suggests that those who habitually consume a low glycaemic index, lowfat diet have an overall reduced risk of CHD (Liu et al, 2000) . A possible explanation for this is the observation that as GI of the diet falls, HDL-cholesterol concentration increases (Frost et al, 1999) .
Coronary bypass grafting has become a common therapy in the management of CHD. Despite this surgery reocclusion occurs in 50% of patients at 10 y and they remain at high coronary risk. There are currently no prospective dietary studies that assess the impact of LGI diets on traditional cardiac risk factors in people with established coronary disease. This study aims to address this. We postulate that patients with established CHD who have undergone coronary bypass grafting will achieve additional cardiovascular protection when LGI carbohydrates are included in the currently prescribed diet based on healthy eating. An additional aim was to investigate whether volunteers were able to change the glycaemic index of the diet in the home situation following verbal advice, rather than supplying food products to them.
Methods
We conducted a randomised parallel group trial comparing a control group who received currently advocated healthy eating dietary advice only, to an intervention group who received healthy eating advice emphasising LGI carbohydrates over a 12-week period in free-living patients with CHD. All volunteers were selected from the cardiac intervention database that lists those who have undergone coronary artery bypass grafting or cardiac angioplasty. All patients entered on to the database in 1997 and 1998 received a letter inviting them to participate (n ¼ 575) and, if interested, to reply in writing using a prepaid envelope. Previous experience suggested that this method of recruitment would give us 10-15% positive replies.
Inclusion criteria: Male and female subjects were between the ages of 30 and 70 y. Patients had to fulfil the following CHD inclusion criteria: (1) myocardial infarction (chest pain associated with ECG evidence of myocardial infarction and/ or elevated cardiac enzymes); (2) unstable angina (cardiac pain associated with dynamic ECG abnormalities); or (3) angiographically proven coronary artery disease (450% stenosis in one or more major epicardial vessels in multiple projections).
Exclusion criteria: These included cardiomyopathy, serious organ disease, systemic illness, chronic alcohol abuse, serious psychiatric illness, poor compliance with a 7-day food diary of habitual diet or failed medical screening.
We received 60 positive replies: 57 met the inclusion criteria, 55 patients completed the study of which 49 were male. Hammersmith Hospital's research ethics committee approved the study. All volunteers gave informed written consent.
Nutritional interventions
All nutritional advice was given on a one-to-one counselling, with patients being asked to comply with the dietary advice over the 12 weeks of the study. To this end, they were supported with regular visits to the unit and telephone calls. The aim was to provide advice rather than a supply of foods in order to assess compliance and outcomes on an intentionto-treat basis.
Healthy eating advice. This intervention was based on current health education guidelines advocated by the COMA panel (Cardiovascular Review Group, 1994) . The aim of the diet intervention was to provide a diet with 50% carbohydrate and 35% of total energy as fat. Unrefined high cereal fibre carbohydrates were encouraged and the fat content was specified to be o10% saturated fat, 10% polyunsaturated fat and 15% monounsaturated fat. A daily target of five portions of fruit and vegetables was set. Weight loss advice: All patients with a body mass index of 428 kg/m 2 were given advice to lose weight. Targets were based on a 1 kg weight loss per month. This was based on previously reported methodology. In brief, energy expenditure was assessed by Schofield's formula (Schofield et al, 1985) with addition for physical activity; 500 kcal was taken from this. This was then based on the health eating advice above.
Low-glycaemic advice. In this group, the aim was to provide healthy eating advice similar to that in the control group with weight loss advice if indicated. However, the diets differed by emphasising the use of at least one LGI food (carbohydrate with a glycaemic index o85 (reference to bread)) at each meal. The liberal use of the following carbohydrates was encouraged: pasta, basmati or easy-tocook rice, whole-grain foods, granary breads, whole fruit, beans, pulses, vegetables or milk. The monitoring of previous studies has demonstrated that this dietary intervention produces a consistent decrease in the GI index of the diet by 20% while keeping overall energy intake and other macronutrients constant (Frost et al, 1996) . A 20% fall in GI has been consistently shown to produce a measurable change in insulin sensitivity (Frost et al, 1998) .
Anthropometric and biochemical outcome measures
All outcome measures were assessed at the baseline visit (week 0) and at the last study visit (week 12).
Dietary assessment and anthropometry outcome measures. Dietary assessment: Volunteers were asked to keep a 7-day diet diary on four occasions during the study. This methodology has been shown to relate closest to actual energy intake. The diaries were validated against estimated energy expenditure using Schofield's equation. A difference of 730% was taken as a measure of accuracy and was used as an indicator of dietary compliance.
Calculation of nutritional intake:
The nutritional content of the 3-day diet diary was calculated using computerised food tables Dietplan5 (Forrest Hill Software Ltd, Sussex, UK). The GI of each diary was calculated using validated methodology that has been reported in the past (Wolever, 1990) . The GI figures were taken from the world literature with main reference to the international table of glycaemic index (Foster-Powell et al, 2002) . Glycaemic load was calculated using published methodology (Salmeron et al, 1997) .
Height was measured by standard protocol with subjects not wearing shoes using a wall-mounted standiometer. Measurements were taken to the nearest centimetre. Weight was taken in light clothing, again following standard procedure on digital scales accurate to 100 g. Waist circumference was measured according to the EEC guidelines; blood pressure was recorded using standard methodology taking three readings, and the average was recorded.
Biochemical outcome measures.
In an attempt to reduce individual variation in the blood biochemistry results, all subjects were asked to fast for 12 h before each assessment. The nutrient content of the last meal before each test was standardised for that individual. Subjects were asked to refrain from smoking and drinking alcohol the evening before the test. 1. Fasting glucose and insulin. Insulin sensitivity was calculated using the HOMA analysis. Insulin was assessed by a published internal radioimmunoassay, and plasma glucose by a standard enzymatic (glucose oxidase) method. Three fasting blood samples were taken for analysis to allow for the pulsatile release of insulin. 2. Fasting total cholesterol, HDL-cholesterol, VLDL-cholesterol, LDL-cholesterol and TG. All these lipoprotein measurements were performed in collaboration with Dr R Chapman, Department of Chemical Pathology at Hammersmith Hospital.
Study protocol
Each subject visited the hospital on five occasions over the 12 weeks of the study. Between each visit, all subjects received telephone support from the dietitians. Visit 1Fthe screening visit (1 month prior to randomisation): Verbal information on the study was given over telephone prior to this screening visit. Following a detailed explanation of the study by the research dietitian, all subjects completed a screening clinical history questionnaire and underwent a full medical assessment (including electrolyte screen, ECG and review of case notes) to assess suitability for the study. This assessment recorded a detailed cardiac history, including a family history of CHD. Patients were then seen by the study dietitian (CB-T) and were asked to complete a 7-day food diary before their next hospital visit, which was used as the basis for the recommended dietary changes for the study diets. Comparing the reported energy intake from the dietary record against the estimated energy expenditure, the accuracy of this record was assessed. Any patient whose dietary record was 725% was asked to redo the record. If this discrepancy persisted, the patient was not randomised.
Visit 2Fbaseline visit (week 0): This visit was conducted on an individual basis between the patient and the study dietitian. Randomisation was carried out using random numbers. The interview focused on instructing the subject on their randomised diet. Volunteers were counselled individually about the diet that they would be expected to follow over 12 weeks. Each volunteer was given written advice and targets to meet for the next appointment. For both dietary interventions, if the volunteer's body mass index was above 25 kg/m 2 , they were encouraged to lose weight using the methodology we have described before (Frost et al, 1991) . Baseline anthropometric measurements, blood biochemistry, and three fasting glucose and insulin samples taken over half an hour were also collected. Visits 3 and 4Fstudy visits (weeks 4 and 8): These visits were a one-to-one visit between the dietitian and the patient. The food diary from the previous month was discussed with the study dietitian and any new dietary targets agreed. Dietary advice was given in a supportive educational way to encourage maximum compliance. Calculated energy intake was compared with estimated energy expenditure (using Schofield's equation) to check the accuracy of the 7-day food diary and the extent of dietary compliance.
Visit 5Fend of study visit (week 12): At this visit, all outcome measures were recorded.
Statistical analysis
Power analysis was based on data from an intervention study by Jenkins et al (1985) , which investigated the effect of GI on total cholesterol and TG in hyperlipidaemic patients, and Frost et al (1994) , which demonstrated a significant improvement on total cholesterol in type II diabetics. All data were checked for normality and presented as means with s.e.m. unless otherwise stated. Statistical comparison within or between groups was made using analysis of variance with Bonferroni post hoc analysis and w 2 as appropriate, taking a P-value of o0.05 as significant.
Results
The demographic details of those that completed the study are shown in Table 1 . Despite the blind randomisation statistically more of the 29 subjects randomised to the healthy eating group than the 26 subjects in the LGI group took an aspirin (29 vs 19, w 2 ¼ 10.4, Po0.002) and a statin (25 vs 15, w 2 ¼ 5.6, Po0.02). Table 2 . No person was excluded for the study due to underor over-reporting. At baseline, the only significant difference between the habitual nutritional intakes of the two groups was in sucrose; this became non-significant after the intervention. Note that at the beginning of the study, the nutritional intakes were not too dissimilar from the healthy eating guideline of 50% carbohydrate and 35% of total energy as fat, which the study aimed to encourage in both groups. Over the 12-week period of the study, there was a significant change in the nutritional content of both study groups. In the LGI group at week 12, there was not only a significantly low GI but an increase in dietary fibre intake and a decrease in sucrose intake but a maintaining of overall carbohydrate intake. The aim of the study was to induce a 20% drop in GI; but this was not achieved, with a decrease in GI of 13%. On the healthy eating group, significant changes were seen in total energy and sugar intake. Comparison between the groups showed a significantly low GI and significantly higher fibre intake in the LGI group. Also of interest are the results of the glycaemic load analysis, with a significant decrease occurring in the LGI group (19578 to 164711 GI units, Po0.01). There was no significant difference between the glycaemic load at week 12 (LGI 164711 vs health eating 15279). This reflects a significant drop in the carbohydrate intake in the healthy eating group compared to the LGI group (health eating 201710 g/day vs
Dietary analysis from both interventions is shown in
LGI 245716 g/day, Po0.01). Table 3 shows the anthropometric and biochemical outcome measures. At baseline (week 0), there was no significant difference between the groups. Over the period of the study, there was no significant difference between the groups for any of the variables measured. Comparison between groups at week 12 showed no difference between the groups, suggesting no additional benefits of an LGI diet in this group of subjects. 
Discussion
Epidemiological evidence suggests that groups that habitually consume an LGI or low-glycaemic load diets have a lower coronary risk (Liu et al, 2000) . However, we are unaware of any prospective study that assesses the efficacy of the introduction of an LGI diet in patients with established and treated coronary disease. We have shown in the past that compliance to an LGI diet over a 3-week period has positive effects on insulin sensitivity and hyperinsulinaemia, an independent risk factor for CHD, in cohorts with coronary disease and offspring of those with a family history of CHD (Frost et al, 1996 (Frost et al, , 1998 . Populations most at risk of a cardiac event and so with most to gain from improved coronary risk factor profiles are those with preexisting CHD. This study was designed to build on our initial studies and assess the benefits of low glycaemic advice when added to traditional healthy eating advice in a randomly selected cohort of patients with established CHD.
Volunteers in the LGI group demonstrated in a free-living situation (without the supply of specific LGI foods), following verbal advice where they had free access to food, that they could significantly lower their GI of the diet by 12% (8172 to 7171, Po0.01), which also caused an increase in dietary fibre by 12% (2472 to 27, p ¼ 0.01). Also of interest is the fall in sucrose in the LGI advice which was a target for healthy eating, again suggesting that the advice was taken up by the volunteers. However, this had no impact on any of the anthropometric or biochemical outcome measures. There are a number of possibilities for this: firstly, the aim of the study was to produce a drop in GI of 20%, which we have shown to have a positive effect on insulin sensitivity in people with CHD (Frost et al, 1996 (Frost et al, , 1998 . In these studies, subjects were supplied with LGI products such as pumpernickel bread. This may be important as most breads sold in the UK have HGI. This drop in GI of 20% was not achieved; however, new data from our centre have shown changes in insulin sensitivity, with a 15% decrease in dietary GI (Goff et al, 2003) . Also, although the LGI group demonstrated a significantly lower GI after 12 weeks, there was no significant difference in the glycaemic load. The reason for this was different in the two groups. In the LGI group, the low glycaemic load was caused by a decrease in GI while carbohydrate intake remained the same; in the healthy eating group, the drop in glycaemic load was due to a drop in carbohydrate intake. It is still unclear as to whether this would mask the results in the drop in GI. Evidence from the work of Wolever's group and ours suggests that highcarbohydrate and low-glycaemic mix has greater efficacy as far as cardiac risk factors are concerned.
A point to note is that the baseline diet in both groups demonstrated a low percentage contribution to total energy of dietary fat intake and profile of saturated, monounsaturated and polyunsaturated fats that was close to the range recommended to reduce cardiac risk. Also the beneficial effects of the dietary intervention in both groups may have been hidden due to the polypharmacy used to treat these patients. For example, in both groups the use of statins, asprin and angiotensin converting enzyme inhibitors was common, with a statistically higher usage of aspirin and statins in the healthy eating control group. This raises the question that if the groups had equal pharmacological intervention, would the results have been the same? Considering that there are very little within-group differences within the LGI group, this is unlikely. With both groups having a total cholesterol concentration of o5 mmol/l at the start of the study, it is unlikely that dietary intervention would make a further significant impact on cholesterol concentration. Also, a number of recent reports suggest that both statin therapy (Paolisso et al, 2000) and aspirin improve insulin sensitivity (O'Keefe et al, 1999) . If this is the case, it may be that the insulin sensitising effects of the LGI diet were masked by the higher statin and aspirin usage in the control group. In our previously reported work (Frost et al, 1996) where significant differences had been detected, statin and asprin usage had not been so widespread.
This study provides evidence that compliance to the LGI diet in this free-living cohort with coronary disease is good.
The LGI advice appears to have had a positive effect on the total fibre intake at 12 weeks; also, there is a significant reduction in energy intake in this group. In people with preexisting coronary disease, whose cardiovascular risk factors are managed by polypharmacy, it was not possible to detect any additional benefit of LGI diet above the healthy eating intervention.
